科研级Pagibaximab(帕昔单抗) Anti-Lipo
teichoic Acid重组抗体 Lipoteichoic Acid[Staphylococcus epidermidis]参照抗体- ￥500 - 3200
- 卡梅德/KMD Bioscience
- YR1165
- 天津市
- 2025年09月04日
- FuncS, IF, Neut, ELISA, FCM, IP
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体英文名：
Anti-Staphylococcus Epidermidis Lipoteichoic Acid Recombinant Antibody
- 靶点：
Lipoteichoic Acid[Staphylococcus epidermidis]
- 浓度：
1mg/ml
- 应用范围：
FuncS, IF, Neut, ELISA, FCM, IP
- 保质期：
一年
- 抗原来源：
体外表达
- 级别：
科研使用
- 库存：
999
- 供应商：
卡梅德生物科技（天津）有限公司
- 克隆性：
Monoclonal
- 保存条件：
It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
- 形态：
液体/冻干粉
- 亚型：
IgG1 Kappa
- 规格：
100ug/1mg
| 规格： | 100ug | 产品价格： | ￥500.0 |
|---|---|---|---|
| 规格： | 1mg | 产品价格： | ￥3200.0 |
产品编号：YR1165
产品名称：Anti-Staphylococcus Epidermidis Lipoteichoic Acid Recombinant Antibody
分子名称：Pagibaximab
产品别称：科研级 Pagibaximab ( 帕昔单抗 ), Anti-Lipoteichoic Acid Recombinant Antibody, Research Grade Pagibaximab
CAS号：595566-61-3
靶点：Lipoteichoic Acid[Staphylococcus epidermidis]
抗体亚型：IgG1 Kappa
克隆性：Monoclonal
来源：CHO Cells
规格：100ug, 200ug, 1mg, 5mg, 10-100mg定制包装
浓度：1mg/ml
纯度：>95% as determined by SDS-PAGE
产品应用：FuncS, IF, Neut, ELISA, FCM, IP
缓冲体系：PBS, pH7.5
产品背景：Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight. As of March 2010, it is undergoing Phase II/III clinical trials.
保存条件：It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
运输条件：Shipped on ice packs.
Note：仅供科研使用
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Anti-PEG IgM Production via a PEGylated Nano-Carrier System for Nucleic Acid Delivery
their long-circulating properties when they are injected repeatedly at certain intervals in the same animal. This unexpected and undesirable phenomenon is referred to as the accelerated blood clearance (ABC) phenomenon. Anti-PEG IgM produced in response
Design and Synthesis of Antioxidant -Lipoic Acid Hybrids
the most important synthetic methodologies we have applied for the preparation of hybrid compounds containing the “universal antioxidant” α -lipoic acid. Experimental details for the synthesis and purification techniques of specific examples of molecules
Methods for the Detection of D-Amino-Acid Oxidase
then twice for 5 min. It was incubated for 1 hr in TBS-T containing rabbit anti-hog D-amino-acid oxidase IgG (1/3,000 dilution) and quickly rinsed twice with TBS-T and further washed in TBS-T once for 15 min then twice for 5 min. The membrane was incubated
技术资料暂无技术资料 索取技术资料
